These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26909485)

  • 1. Insights into the posttranslational structural heterogeneity of thyroglobulin and its role in the development, diagnosis, and management of benign and malignant thyroid diseases.
    Xavier AC; Maciel RM; Vieira JG; Dias-da-Silva MR; Martins JR
    Arch Endocrinol Metab; 2016 Feb; 60(1):66-75. PubMed ID: 26909485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels.
    Pellegriti G; Scollo C; Regalbuto C; Attard M; Marozzi P; Vermiglio F; Violi MA; Cianci M; Vigneri R; Pezzino V; Squatrito S
    Clin Endocrinol (Oxf); 2003 May; 58(5):556-61. PubMed ID: 12699436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma.
    Gholamrezanezhad A; Saghari M; Mirpour S; Beiki D; Tarbiat A; Javan S; Abdollahzadeh J
    Endokrynol Pol; 2007; 58(2):100-4. PubMed ID: 17578824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
    Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
    Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of thyroid hormone residues on serum thyroglobulin: a clue to the source of circulating thyroglobulin in thyroid diseases.
    Druetta L; Bornet H; Sassolas G; Rousset B
    Eur J Endocrinol; 1999 May; 140(5):457-67. PubMed ID: 10229914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin Preparations Can Mislead Clinical Decision-Making in Follow-Up of Differentiated Thyroid Cancer.
    Yéléhé-Okouma M; Malaplate C; Petitpain N; Metallo M; Ziegler F; Klein M; Guerci B; Feigerlová E
    Endocr Pract; 2020 Sep; 26(9):1031-1038. PubMed ID: 33471692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of thyroglobulin structure for thyroid hormone biosynthesis.
    Dunn JT; Dunn AD
    Biochimie; 1999 May; 81(5):505-9. PubMed ID: 10403182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryo-EM structure of native human thyroglobulin.
    Adaixo R; Steiner EM; Righetto RD; Schmidt A; Stahlberg H; Taylor NMI
    Nat Commun; 2022 Jan; 13(1):61. PubMed ID: 35013249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thyroglobulin in the monitoring of differentiated thyroid cancer.
    Evans C; Tennant S; Perros P
    Scand J Clin Lab Invest Suppl; 2016; 245():S119-23. PubMed ID: 27542000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma.
    Xu S; Huang H; Zhang X; Huang Y; Guan B; Qian J; Wang X; Liu S; Xu Z; Liu J
    Thyroid; 2021 Sep; 31(9):1391-1399. PubMed ID: 34340593
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
    Koh JM; Kim ES; Ryu JS; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic modalities in patients affected by differentiated thyroid carcinoma with high thyroglobulin levels and total body Iodium-131 negative: PET/CT use after recTSH].
    Biscontini G; Possa M; Sara R; Milella M; Rossetti C
    Minerva Endocrinol; 2004 Dec; 29(4):151-60. PubMed ID: 15765025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and tissue thyroglobulin measurement: clinical applications in thyroid disease.
    Pacini F; Pinchera A
    Biochimie; 1999 May; 81(5):463-7. PubMed ID: 10403176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in thyroglobulin assays and their impact on the management of differentiated thyroid cancers].
    d'Herbomez M; Lion G; Béron A; Wémeau JL; DoCao C
    Ann Biol Clin (Paris); 2016; 74(1):21-7. PubMed ID: 26711165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
    Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
    J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowered cutoff of lymph node fine-needle aspiration thyroglobulin in thyroid cancer patients with serum anti-thyroglobulin antibody.
    Jo K; Kim MH; Lim Y; Jung SL; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
    Eur J Endocrinol; 2015 Oct; 173(4):489-97. PubMed ID: 26208979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient early increase in thyroglobulin levels post-radioiodine ablation in patients with differentiated thyroid cancer.
    Stevic I; Dembinski TC; Pathak KA; Leslie WD
    Clin Biochem; 2015 Jul; 48(10-11):658-61. PubMed ID: 25895485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THYROGLOBULIN AS A TUMOR MARKER IN DIFFERENTIATED THYROID CANCER - CLINICAL CONSIDERATIONS.
    Prpić M; Franceschi M; Romić M; Jukić T; Kusić Z
    Acta Clin Croat; 2018 Sep; 57(3):518-527. PubMed ID: 31168186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.